When comparing baseline laboratory test results with current results (
Table 2), his HbA
1c decreased from 7.8% to 7.4%. Dave's fasting glucose and mean glucose levels also decreased (187 mg/dL to 132 mg/dL and 177 mg/dL to 166 mg/dL, respectively).
Liver function studies, electrolytes, serum urea nitrogen/creatinine ratio, and urine for microalbumin were all normal at baseline and at presentation. Lipid profile, taken at diagnosis, revealed a total cholesterol of 154 mg/dL; low-density lipoprotein cholesterol, 68 mg/dL; high-density lipoprotein cholesterol, 58 mg/dL; and triglycerides, 89 mg/dL. His calculated non–high-density lipoprotein cholesterol was 96 mg/dL.
Given Dave's profile at baseline and then 2 months later at presentation, you must consider how to move forward in terms of treating this patient.